Impact of MK-0954A on Uric Acid in the Management of Hypertension (MK-0954A-366)
NCT01368185 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1705
Last updated 2022-02-09
Summary
This was a retrospective, chart review, observational study to assess the effect of MK-0954A (losartan potassium 50 mg + hydrochlorothiazide 12.5 mg \[Hyzaar(R)\]) treatment for a period of at least three months on serum uric acid levels.
Conditions
Sponsors & Collaborators
-
Organon and Co
lead INDUSTRY
Eligibility
- Min Age
- 20 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-11-30
- Primary Completion
- 2010-08-31
- Completion
- 2010-08-31
More Related Trials
-
Study of Febuxostat Effect on Blood Pressure in Patients With High Normal Blood Pressure
NCT01472692 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess Efficay and Safety of LC350189 Different Doses in Gout Patients With Hyperuricemia
NCT03934099 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults
NCT06139393 ·Status: COMPLETED ·Phase: PHASE3
-
Febuxostat, Blood Pressure and the Intrarenal Renin-Angiotensin System (RAS)
NCT01328769 ·Status: COMPLETED ·Phase: PHASE4
-
Prednisone for Heart Failure Patients With Hyperuricemia
NCT02129764 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Efficacy Study of Intramuscular Uricase-PEG 20
NCT01038947 ·Status: UNKNOWN ·Phase: PHASE1
-
A Safety and Efficacy Study of SHR4640 and Febuxostat in Subjects With Hyperuricemia
NCT04180982 ·Status: UNKNOWN ·Phase: PHASE2
-
Prednisone for Heart Failure Patients With Hyperuricemia
NCT00919243 ·Status: COMPLETED ·Phase: PHASE4
-
Phase 2 Study of URC102 to Assess the Efficacy and Safety in Gout Patients
NCT02290210 ·Status: COMPLETED ·Phase: PHASE2
-
Uric Acid and Hypertension in African Americans
NCT00241839 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Hyperuricemia Reversal on Features of the Metabolic Syndrome
NCT01654276 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Hyperuricemia in Patients With Heart Failure
NCT00422318 ·Status: COMPLETED ·Phase: PHASE4
-
Rasburicase in Tumor Lysis Syndrome
NCT00302653 ·Status: COMPLETED ·Phase: PHASE4
-
A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic Hyperuricemia
NCT06859073 ·Status: RECRUITING ·Phase: PHASE1
-
Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout
NCT01129648 ·Status: COMPLETED ·Phase: PHASE2
-
Post-Authorisation Safety Study of Lesinurad
NCT04072471 ·Status: WITHDRAWN
-
Clinical Trial of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults
NCT06414837 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Safety and Efficacy Study of Intravenous Uricase-PEG 20
NCT01021241 ·Status: UNKNOWN ·Phase: PHASE1
-
Study of Tranilast Alone or in Combination With Febuxostat in Patients With Hyperuricemia
NCT00995618 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout
NCT00985127 ·Status: COMPLETED ·Phase: PHASE2
-
Intensive Urate Lowering Therapy of Febuxostat Compared to Allopurinol on Cardiovascular Risk in Patients With Gout
NCT02500641 ·Status: COMPLETED ·Phase: PHASE4
-
Study of FYU-981 in Hyperuricemia With or Without Gout
NCT02344862 ·Status: COMPLETED ·Phase: PHASE2
-
Orlistat Reduces Uric Acid in Overweight/Obese Patients With Hyperuricemia
NCT05496075 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy Study of MBX-102 in Treatment of Hyperuricemia in Patients With Gout
NCT01336686 ·Status: COMPLETED ·Phase: PHASE2
-
The Influence of Urate-lowering Therapy on Sperm Quality of Male Gouty Patients：A Prospective Cohort Study
NCT04213534 ·Status: UNKNOWN